INO stock: buy or sell

INO stock price: $10.58 8.85% At close on Jan 26th, 2021

Updated on:
Jan 27th, 2021


INO stock brief

  • Inovio Pharmaceuticals closed on Tuesday at $10.58 after exploding a 8.85% and broke a streak of 3 sessions in negative.
  • The price is currently over the upper Bollinger band, which usually indicates a short-term correction
  • On Tuesday broke out above its latest top at $10.57

Should I buy Inovio Pharmaceuticals stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $INO stock a buy?

In the current situation of Inovio Pharmaceuticals there is not any eligible buy setup. This doesn't mean $INO will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Inovio Pharmaceuticals stock?

When is it time to sell Inovio Pharmaceuticals stock?. Trading strategies allow us to avoid rash decisions based on our personal feelings or the noise surrounding the market. When selling, as well as buying, detailed strategies are very simple to use and are only applicable for selling shares you already own, not for shorting $INO stock

A golden rule is that you should not mantain an open trade that leads to greater losses than those expected at the time of the buy. The timing to sell your stock always has to be dictated by the stop-loss (automatic or manual)

Is it time to sell Inovio Pharmaceuticals stock?

Currently, Inovio Pharmaceuticals stock doesn't match any of our preferred sell setups, so if you own Inovio Pharmaceuticals stock and your operation is in profit probably is not time to sell now

Inovio Pharmaceuticals ratings

In the last 30 days, just one analyst rating was published for Inovio Pharmaceuticals

Inovio Pharmaceuticals analysts' ratings - Last month
Brokerage firmRating
Jan 8th, 2021
Benchmark Strong buy

Inovio Pharmaceuticals stock analysis

SMAs overview

INO stock SMAs chart

Supports and resistances

The current resistance levels are:

  • R1: $10.60 (0.19% above)
  • R2: $10.83 (2.36% above)
  • R3: $11.00 (3.97% above)
  • The current supports are:

  • S1: $10.57 (-0.09% below)
  • S2: $10.24 (-3.21% below)
  • S3: $9.95 (-5.95% below)
  • Bollinger bands

    When the price moves out of the band (above the upper line or below the lower line) it indicates that the price action is having a very strong momentum and therefore can correct the trend to the average. At this point, the price is above the upper band, and that should mean a near-term correction (at least) until it is below the band

    INO stock Bollinger Bands chart

    Relative strength index

    The has been between the levels of 70 and 30 for several weeks, and therefore, without this indicator really being helpful in making any decisions.

    INO stock RSI chart

    Inovio Pharmaceuticals stock price history

    Inovio Pharmaceuticals went public priced at an adjusted price1 of $60.00 on Dec 1998. Since then, INO stock depreciated by -82.37%. An investment of thousand dollars on Dec 1998 would worth $176.33 nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    INO stock price history chart

    Price target for Inovio Pharmaceuticals stock

    Nobody can predict how much a stock will be priced tomorrow. However, many stock price predictions are issued every day by banks, financial institutions and independent analysts.

    Along with buy or sell recommendations, brokerage institutions publish their price target based on the stock price action and the company fundamental data. Most of these predictions follow the publication of new fundamental information by the company, and many times. If you are a small trader you shouldn't invest based on these predictions.

    There is just one price target issued for Inovio Pharmaceuticals that predicts a price of $15.00.

    Inovio Pharmaceuticals stock price predictions
    Brokerage firmPrice target
    Jan 8th, 2021
    Benchmark $25.00$15.00

    Earnings and financials

    Inovio Pharmaceuticals, Inc. ($INO) came out with quarterly earnings of $-0.26 per share last November, poorly worsening the Wall St consensus estimate of $-0.19 per share. This Q3 report means an earnings surprise of -36.84%. Company's turnover was $236.2 million compared to $3.1 million forecasted by market consensus.

    In comparing, the EPS for the same quarter last year was $-0.25, so posted EPS is a drop of -4.00%. Turnover tanked a -72.75% on an annualized basis in the , from $8.7M to $2.4M last quarter.

    INO ($INO) will host the earnings call next March.

    Inovio Pharmaceuticals performance

    INO performance compared
    Inovio Pharmaceuticals ($INO) -3.40% -0.80% -48.30%

    The opinions written in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this document does not know the individual situations of the reader, his or her own finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are published for education purposes only

    INO summary

    Tuesday, January 26th, 2021
    Day range$9.5 - $10.68
    Previous close$9.72
    Session gain8.85%
    Average true range$0.69
    50d mov avg$10.48
    100d mov avg$11.26
    200d mov avg$13.82
    Earnings dateMarch 11th, 2021

    Frequently asked questions

    What is Inovio Pharmaceuticals stock symbol?

    Inovio Pharmaceuticals, Inc. is a public company trading in the US stock market with the INO symbol

    Is Inovio Pharmaceuticals stock a buy or sell?

    Inovio Pharmaceuticals had one rating in the last four weeks Read the article to get additional tips on trading INO stock.

    Will INO go up?

    Inovio Pharmaceuticals had different price forecasts published by market analysts in the last month setting the target price to $15.00. That is a 41.78% than the last price ($10.58).